Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan/HCTZ versus valsartan monotherapy as initial treatment for severe hypertension
2005-003376-37Phase 3Completed
- Sponsor
- Novartis
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hypertension (HTN) comparing Valsartan + hydrochlorothiazide with Valsartan monotherapy (2 arms). Primary endpoint: Blood pressure control rate at Week 4. Started Nov 2005; status: completed.
02
Drugs
valsartanhydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2005-003376-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003376-37.